Meeder Asset Management’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-1,362
| Closed | -$22K | – | 2609 |
|
|
2021
Q1 | $22K | Buy |
+1,362
| New | +$22K | ﹤0.01% | 1375 |
|
|
2020
Q2 | – | Sell |
-4,725
| Closed | -$23K | – | 2324 |
|
|
2020
Q1 | $23K | Buy |
4,725
+3,625
| +330% | +$17.6K | ﹤0.01% | 1189 |
|
|
2019
Q4 | $4K | Hold |
1,100
| – | – | ﹤0.01% | 1853 |
|
|
2019
Q3 | $3K | Buy |
1,100
+192
| +21% | +$524 | ﹤0.01% | 1887 |
|
|
2019
Q2 | $4K | Buy |
908
+174
| +24% | +$767 | ﹤0.01% | 1729 |
|
|
2019
Q1 | $3K | Sell |
734
-1,335
| -65% | -$5.46K | ﹤0.01% | 1505 |
|
|
2018
Q4 | $8K | Buy |
2,069
+1,462
| +241% | +$5.65K | ﹤0.01% | 1308 |
|
|
2018
Q3 | $4K | Buy |
+607
| New | +$4K | ﹤0.01% | 1372 |
|
|
2017
Q2 | – | Sell |
-756
| Closed | -$7K | – | 1808 |
|
|
2017
Q1 | $7K | Sell |
756
-1,132
| -60% | -$10.5K | ﹤0.01% | 956 |
|
|
2016
Q4 | $16K | Buy |
1,888
+1,388
| +278% | +$11.8K | ﹤0.01% | 683 |
|
|
2016
Q3 | $3K | Buy |
+500
| New | +$3K | ﹤0.01% | 726 |
|